MDoutlook is a leading precision intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, hematology, and rare diseases, we answer your business questions with timely precision intelligence using custom marketing research instruments, secondary data sources, our proprietary access to communities [clinicians, ThoughtLeaders and other stakeholders] and our seasoned in-house expertise from across the industry.

Driven by staff medical experts and supported by business consultants, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides agile research-based consulting, custom and syndicated market research,  secondary data analysis & intelligence, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the icons above to explore how our clients derive value.

What's New at MDoutlook

Hyper-targeting Oncologists

30 Oct 2019

Whilst the importance of conferences such as ASCO and ASH are acknowledged this mantle is shared more than ever today. ESMOs importance has grown significantly…


The treatment landscape for prostate cancer is changing

16 Oct 2019

Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted…


Driving impactful outcomes through precision intelligence

02 Oct 2019

MDoutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation…


What's Trending in Oncology (updated hourly)